MOLECULAR CELLULAR BIOLOGY, Sept. 2007, p. 6084â€“6092                                                                            Vol. 27,  17
0270-7306/07/$08.00â«¹0 doi:10.1128/MCB.00647-07
Copyright Â© 2007, American Society Microbiology. Rights Reserved.



 2â¬˜-O-Ribose Methyltransferase Cap 1 Spliced Leader RNA
         U1 Small Nuclear RNA Trypanosoma bruceiäŒ¤â€ 
         Jesse R. Zamudio,1 Bidyottam Mittra,1 Silvie FoldynovaÂ´-TrantÄ±Â´rkovaÂ´,1,2 Gusti M. Zeiner,1â€¡
               Julius LukesË‡,2 Janusz M. Bujnicki,3 Nancy R. Sturm,1* David  Campbell1
         Department Microbiology, Immunology Molecular Genetics, David Geffen School Medicine, University          California Los Angeles, Los Angeles, California 90095-14891; Biology Centre, Czech Academy Sciences,           Faculty Biology, University South Bohemia, 37005 CË‡ eskeÂ´ BudeË‡jovice, Czech Republic2; Laboratory                    Bioinformatics Protein Engineering, International Institute Molecular Cell Biology,
                                  Warsaw, Institute Molecular Biology Biotechnology,
                                            Adam Mickiewicz University, Poznan, Poland3
                                                Received 12 April 2007/Accepted 18 June 2007

             mRNA cap 1 2â´•-O-ribose methylation widespread modification implicated processing, traf-
          ficking, translational control eukaryotic systems. eukaryotic enzyme identified.           kinetoplastid flagellates trans-splicing spliced leader (SL) polycistronic precursors conveys hyper-
          methylated cap 4, including cap 0 m7G seven additional methylations 4 nucleotides,           nuclear mRNAs. report eukaryotic cap 1 2â´•-O-ribose methyltransferase, TbMTr1, member           conserved family viral eukaryotic enzymes. Recombinant TbMTr1 methylates ribose           nucleotide m7G-capped substrate. Knockdowns null mutants TbMTr1 Trypanosoma brucei grow
          normally, loss 2â´•-O-ribose methylation cap 1 substrate SL RNA U1 small nuclear RNA.
          TbMTr1-null cells accumulation cap 0 substrate methylation, spliced mRNA
          modified efficiently position 4 absence 2â´•-O-ribose methylation position 1; downstream cap 4
          methylations independent cap 1. Based TbMTr1-green fluorescent protein localization, 2â´•-O-ribose
          methylation position 1 occurs nucleus. Accumulation 3â´•-extended SL RNA substrate indicates           delay processing suggests synergistic role cap 1 maturation.


   m7G cap eukaryotic mRNA plays essential roles                      Trypanosoma cruzi, transcribed polycistronically (23,
translation stability, enzymatic activities responsi-               36). discrete spliced leader (SL) RNA serves donor ble formation characterized (48, 50). Additional               39 nucleotides (nt) unique cap structure modifications adjacent nucleotides mRNA small                         coding regions trans-splicing. addition m7G, hy-
nuclear RNA (snRNA) documented;                            permethylated cap 4 structure includes 2â¬˜-O-ribose methyl-
identity eukaryotic cap ribose-methylating enzyme(s)                     ations 4 nt (AACU) additional base meth- function cap modification m7G attached                    ylations (m26A) fourth (m3U) positions (5, 16, transcribed nucleotide (cap 0) remain unclear (6,                  41). 5â¬˜ processing SL accompanied association 18). 2â¬˜-O-Ribose methylation common modification                        transcript Sm complex stem-loop
RNA (29) occur mechanisms: box C/D                             structures intron (35, 51, 65) 3â¬˜ trimming residual
snoRNA-guided methylation fibrillarin (12) nucleotide-                   nucleotides attenuated transcription termination specific enzymes (31, 43, 54). conservation modified                     downstream T tract (51, 66). eukaryotic mRNA caps
nucleotides functionally important regions indicates major                 vary containing cap 0 modified benefit cell (13). Individual methylations tRNA                   2â¬˜-O-ribose methylation(s) second essential viability;  cumulative loss                  nucleotides, known cap 1 cap 2, respectively (17).
detrimental (1). Potential functions mRNA 2â¬˜-O-ribose                       higher eukaryotes cap ribose modifications 
methylation include roles processing trafficking tran-                served, majority mRNAs ribose methylated scripts, translational control (4, 45).                              mammals (4).
   Protein-encoding genes kinetoplastid protozoa, including                     unique kinetoplastid cap 4 structure implicated human-pathogenic Leishmania major, Trypanosoma brucei,                      trans-splicing translation. Substrate SLs incomplete
                                                                                cap 4 trans spliced (52);  mRNAs asso-
                                                                                ciate polysomes (68), suggesting role cap 4, primary
   * Corresponding author. Mailing address: Department Microbi-              SL sequence, translation. cap 2â¬˜-O-ribose methyl-
ology, Immunology Molecular Genetics, David Geffen School Medicine, 609 Charles E. Young Drive East, University California             transferases (MTases), TbMT417 TbMT511, modify Los Angeles, Los Angeles, CA 90095-1489. Phone: (310) 206-5556.              second positions cap 4, dispensable survival Fax: (310) 206-5231. E-mail: nsturm@ucla.edu.                                   T. brucei (2, 3, 64). relatives vaccinia virus cap 1
   â€  Supplemental material article http://mcb          MTase henceforth referred TbMTr2 TMTr3,
.asm.org/.
   â€¡ Present address: Department Microbiology Immunology,
                                                                                respectively, reflect functional roles. requirement
Stanford University School Medicine, Stanford, CA 94305.                     TbMTr2 TbMTr3 activities viability, focus    äŒ¤
     Published ahead print 2 July 2007.                                   critical component cap 4 turned position 1.

                                                                         6084
 VOL. 27, 2007                                                                                            RNA CAP 1 RIBOSE METHYLATION                             6085


   kinetoplastid U1 snRNA contains 4 nt                        nuclease P1 50 mM ammonium acetate, pH 5.3, 1 h 37Â°C. RNA samples
SL RNA identical hypermethylation                          analyzed layer chromatography (TLC) polyethyleneimine cellu-
                                                                                     lose plates developed 0.45 M ammonium sulfate (62). TLC results positions monogenetic kinetoplastid Crithidia fasciculata                     visualized PhosphorImager (Amersham Biosciences).
(47). contrast SL RNA, RNA polymerase (pol) II                                 RNAi strains cell culture. Procyclic T. brucei strain 29-13 (61) containing
transcript, U1 snRNA, transcribed RNA pol III                          T7 RNA pol tetracycline (Tet) repressor genes grown 27Â°C SM
ultimately acquires trimethylated m2,2,7G (TMG) cap (14).                          medium supplemented 10  fetal bovine serum presence hygro-
                                                                                     mycin (50 â?®g/ml; PGC Scientific) G418 (15 â?®g/ml; ICN). pRTbMT370 U1 snRNA contains Sm binding sequence likely
                                                                                     p2T7-177-370 constructions transfected 29-13 cells elec-
results formation core Sm-protein complex (39, 40,                         troporation (59). Drug-resistant T. brucei strains cloned limiting dilution
58). Knockdown TbMTr2 effect U1 snRNA cap                               supplemented SM medium presence G418, hygromycin, zeocin.
structure T. brucei (64).                                                         RNAi induced addition 100 ng/ml Tet clonal pRTbMT370    identify cap 1 2â¬˜-O-ribose MTase SL RNA                         p2T7-177-370 cells 1 â«» 106 cells/ml, growth assayed using Coulter
                                                                                     Counter (Beckman-Coulter).
T. brucei, TbMTr1, representing functionally charac-                          RNA analyses. Total cell RNA isolated TRIzol reagent (Invitrogen)
terized member group widely conserved eukaryotic                             described previously (66). High-resolution acrylamide RNA blotting, RNA
MTases. S-Adenosylmethionine (AdoMet)-dependent, cap 1                               primer extension using Moloney murine leukemia virus reverse transcriptase
2â¬˜-O-ribose MTase activity shown vitro. growth defect                       (RT), DNA sequencing reactions performed described previously
                                                                                     (51, 52, 66) using â?¥-32P-labeled oligonucleotides TbWTexon (5â¬˜-CAATA detected knockdown TbMTr1-null lines loss
                                                                                     TAGTA CAGAA ACTG) intron-specific TbSL-40 (5â¬˜-CTACT GGGAG cap 1 methylation substrate SL RNA U1                                 CTTCT CATAC). U1 snRNA extensions performed TbU1-40 (5â¬˜-
snRNA corresponding accumulation substrate SL                               CCCAC TCAAA GTTTA CTG). Low-resolution formaldehyde agarose RNA
3â¬˜-extended forms. TbMTr1 portal identification                          blots generated described previously (52), hybridized [â?£-32P]CTP- eukaryotic cap 1 MTases understanding                              incorporated random hexamer-primed probes (Amersham Biosciences), vi-
                                                                                     sualized PhosphorImager. Poly â«¹ mRNA isolated using functional significance modifications eukaryotic                         MicroPoly  Purist kit (Ambion). RNA blot hybridizations performed
mRNA snRNA.                                                                      TbStloop1 (5â¬˜-CTACT GGGAG CTTCT CATCA), TbU1-20 (5â¬˜-CAAGC
                                                                                     ACGGC GCTTT CGTGA), 5S rRNA (5â¬˜-TAACT TCACA AATCG
                                                                                     GACGG GAT).
                        MATERIALS METHODS                                           RNase T2 cap analysis. mRNA cell line purified using    Sequence analyses. Sequence database searches carried PSI-          MicroPoly  Purist mRNA purification kit (Ambion), starting 10 â?®g total
BLAST, starting putative ribose MTases trypanosomes, predicted         RNA. label cap structure, 300 ng mRNA decapped tobacco acid earlier analyses (15). Phylogenetic analyses carried MEGA 3.1       pyrophosphatase (5 U; Roche) 1 h 37Â°C provided reaction buffer. (26).                                                                                phosphate removed using HK phosphatase (2 U; Epicenter) 1 h 30Â°C.    DNA cloning RNAi constructions. 1,110-bp open reading frame               RNA extracted twice phenol, ethanol precipitated, end labeled (ORF) TbMTr1 (GeneDB  Tb10.6k15.2610) amplified using MT370               [â?¥-32P]ATP T4 polynucleotide kinase. radiolabeled RNA digested 50
Xba-F (5â¬˜-GGTCT AGAAT GCCTG CCGTT GCAGA C) MT370 xh/xb R                         mM ammonium acetate (pH 4.5) 2 mM EDTA 40 U/ml RNase T2 37Â°C
(5â¬˜-GGCTC GAGTC TAGAT GACTT GACCT CCTCC ATTGC) cloned                            12 h. Digestion products resolved 25  acrylamide-8 M urea gels pTOPO-TA (Invitrogen). insert released XbaI subcloned          visualized PhosphorImager. pR hairpin-loop RNA interference (RNAi) vector. pGR vector             Subcellular localization TbMTr1. coding region nt 1001 2110 pLEW100 creation green fluorescent protein (GFP) fusion             amplified pC-PTP-NEO370F (5â¬˜-AGGGC CCATG CCTGC CGTTG)
proteins hairpin-loop, double-stranded RNAi formation available           MT370 xh/xb R (5â¬˜-GGCTC GAGTC TAGAT GACTT GACCT CCTCC request. pRTbMT370 vector digestion pGMT370             ATTGC), digested ApaI XhoI insertion pMOT4G vector
AscI XhoI. XhoI site filled Klenow fragment, gel purified,      situ GFP tagging (38). 3â¬˜ UTR used pKO vectors amplified
inserted pGMT370 digested HpaI MluI. inducible RNAi           BamHI370-3â¬˜UTR-F (5â¬˜-AGGAT CCCAA GTCAT AGGTA GTCC) vector opposing promoters, TbMTr1 amplified using MT370Fw           inserted using BamH NotI sites. Plasmid (10 â?®g) digested ApaI (5â¬˜-CTCGA GGCGC CACGA CCCAG CTTCC) MT370Rv (5â¬˜-GGATC                             NotI, released fragment gel purified electroporated KH4A
CCACG ACTTC GGTGG GAACG) cloned pGEM-T Easy (Pro-                           YTAT T. brucei. Stable transfectants selected 50 â?®g/ml hygromycin,
mega). insert released XhoI BamHI cloned p2T7-177          clonal cell lines limiting dilution. Clonal lines rinsed vector (60). Inserts vectors verified sequencing. Elimination      washed phosphate-buffered saline containing 100 ng/ml 4â¬˜,6â¬˜-di-
TbMTr1 alleles create TbMTr1-null cell lines used pKO vectors (28)            amidino-2-phenylindole (DAPI; Sigma) 5 min room temperature. Live drug selection cassettes replaced phleomycin puromycin           cells mounted microscope slides visualized Zeiss Axiocam
resistance markers. 426-nt, 5â¬˜ untranslated region (UTR) directly upstream       compound fluorescence microscope fitted Zeiss 63â«» objective start codon cloned using TbMT370-5â¬˜UTR-F-HindIII (5â¬˜-AAAGC                digital camera. Images captured Zeiss Axiovision software com-
TTAAA GTCTA TACAA CTGC) TbMT370-5â¬˜UTR-R-EcoRI (5â¬˜-TGAAT                          piled publication Adobe Photoshop 7.0 (Adobe).
TCGGC ATCAG AGAAA TA). 598-nt 3â¬˜ UTR cloned using
TbMT370-3â¬˜UTR-F-Xba (5â¬˜-ATCTA GACAA GTCAT AGGTA GTCC) TbMT370-3â¬˜UTR-R-NotI (5â¬˜-TGCGG CCGCT GAATA TTTCT CCAC).                                                           RESULTS inserted pKOpuro pKOphleo vectors transfected YTAT
cells, selected puromycin (30 â?®g/ml) zeocin (20 â?®g/ml; Invitrogen).
                                                                                        TbMT370 conserved viral eukaryotic 2â´•-O-ribose
   vitro activity assay. Recombinant TbMTr1 T. bracie N-terminal           MTases. Phylogenetic analysis RrmJ superfamily ribose histidine (His6) tag overexpressed Escherichia coli BL21(DE3)pLysS        2â¬˜-O-ribose MTases revealed conserved group uncharacter-
cells purified homogeneity Ni column phosphocellulose chroma-          ized eukaryotic MTases (15) includes putative T. brucei
tography procedures. Synthetic RNA substrate identical T. brucei SL RNA,
                                                                                     MTase encoded 370-amino-acid ORF named guanosine position 2 transcriptional efficiency, synthesized
using PCR-amplified DNA template allows transcription T. brucei      TbMT370 (GeneDB  Tb10.6k15.2610). TbMT370 
SL RNA gene T7âŒ½ 2.5 promoter (11). 142-nt RNA capped                served kinetoplastids homologs T. cruzi
using [â?£-32P]GTP vaccinia virus RNA guanylyltransferase (Ambion)           (GeneDB  Tc00.1047053506247.320) L. major (GeneDB
scribed manufacturer presence 1 mM AdoMet. Radiolabeled              LmjF36.6660). contrast TbMTr2 TbMTr3 vac-
RNA purified extraction phenol-chloroform, followed spin col-
umn chromatography. Cap 1 MTase activity assayed incubating radiola-
                                                                                     cinia virus-like MTases unique kinetoplastids, data-
beled RNA recombinant TbMTr1 1 h 28Â°C followed RNA extrac-            base searches TbMT370 homologs revealed family pro-
tion phenol-chloroform, ethanol precipitation, digestion 5 â?®g          teins members metazoa, protists, double-stranded
 6086     ZAMUDIO ET AL.                                                                                                   MOL. CELL. BIOL.




  FIG. 1. Phylogeny 2â¬˜-O-ribose MTase family. Shown phylogenetic tree sequences calculated neighbor joining method JTT matrix (24). Values nodes indicate percent bootstrap support. main taxa indicated.




DNA viruses share 10 conserved motifs spread               unable cleave 5â¬˜-5â¬˜ triphosphate bond ORF  Fig. S1 supplemental material),           labeled m7G. TLC resolved radiolabeled dinucleotides,
including functionally characterized cap 1 MTase, orf69         methylated species migrate farther alfalfa looper moth Autographa californica nucleopoly-          m7GpppA unmodified marker. presence AdoMet,
hedrovirus (62). members contained characteristic K-D-           m7GpppAm species generated migrated faster
K-E tetrad common 2â¬˜-O-ribose MTases (9, 15). Phylogenetic            m7GpppA marker ribose methylation analysis family showed branches containing viral          nucleotide (Fig. 2B). confirm location cellular proteins (Fig. 1). Interestingly, orf5 European pine       methylation, modified substrate subjected RNase T2
sawfly Neodiprion sertifer nucleopolyhedrovirus branched cel-       digestion, inhibited ribose 2â¬˜-O-ribose methyl-
lular proteins insects, suggesting horizontal transfer       ation. RNase T2 treatment yielded product consistent host. family includes human ortholog TbMT370.          vitro cap 1 formation (data shown). depth gene encoding human cap 1 2â¬˜-O-ribose MTase           biochemical characterization protein pre- identified functionally, activity partially purified   sented  characterized (30).                                                     cap 1 2â¬˜-O-ribose MTase activity TbMT370    determine eukaryotic family member pos-                  kind ascribed eukaryotic cellular protein. 
sesses cap 1 MTase activity, assayed TbMT370 activity             zyme renamed TbMTr1 reflect function. query vitro vivo, specifically candidate SL cap        TbMTr1 role SL cap 4, determined vivo
1 2â¬˜-O-ribose methylation.                                               substrates.
   TbMT370 AdoMet-dependent, 2â´•-O-ribose MTase cap 1                    5â´• 3â´• SL RNA phenotypes TbMTr1 RNAi knockdown
activity vitro. enzymes performing cap 4 2â¬˜-O-             cells. Ribose modifications positions 2, 3, 4 ribose methylations identified (Fig. 2A). biochemical        essential, leaving position 1 ribose base methylations approach initiated vitro evaluation TbMT370        potentially pivotal players cap 4. challenge role 2â¬˜-O-ribose MTase activity. Recombinant TbMT370 ex-                  TbMTr1 cap 1 methylation SL, performed RNAi-
pressed His6 tag bacterial purification.                      mediated knockdown transcript using Tet-inducible
   Recombinant TbMT370 purified homogeneity                       hairpin-loop opposing-T7-promoter RNAi constructions. E. coli. vitro-transcribed 142-nt RNA capped                 induced cells viable, RNAi lines allow cap 1 vaccinia virus m7G capping enzyme using radiola-                status target transcripts assessed various times
beled [â?£-32P]GTP. cap 0 transcript incubated               induction cell death.
purified recombinant TbMT370 presence absence                    RNAi cell lines vector showed signifi- methyl donor AdoMet. liberate 5â¬˜-5â¬˜-linked                     growth defects 9 days postinduction (data shown).
dinucleotides analysis, RNA extracted di-                Total RNA samples collected day 9 probed gested nuclease P1, nonspecific RNA endonuclease                  coding region TbMTr1. induced samples showed effi-
 VOL. 27, 2007                                                                             RNA CAP 1 RIBOSE METHYLATION                  6087




   FIG. 2. TbMTr1 vitro 2â¬˜-O-ribose MTase cap 1 activity.   cap 4 structure identified enzymes. (B) â?£-32P-labeled m7G-capped
transcript incubated recombinant TbMT370 presence (â«¹) absence (â«º) AdoMet. Following digestion nuclease P1,
resistant cap dinucleotides resolved TLC. Dinucleotide identities listed right. ori, origin spotting.



cient knockdown target transcript (Fig. 3A);             knockdowns. capture cap intermediates cap 4 
lack TbMTr1 judged acceptable cells.              mation assay, radiolabeled primer extended used substrate-specific primer extension examine             RT, extension inhibited presence methyl-
cap structure prespliced, substrate SL RNA TbMTr1                  ation base ribose moiety (Fig. 3B); stop




  FIG. 3. RNAi TbMTr1 induces defects SL RNA U1 snRNA methylation SL RNA 3â¬˜-end formation.   RNA collected 9 days pRTbMTr1 cells grown presence (â«¹) absence (â«º) Tet run 1.1  formaldehyde agarose gel, blotted, probed TbMTr1 coding region. Ethidium bromide-stained rRNA loading control. (B) Schematic cap 4 showing possible primer
extension products interpretations intermediate cap structures. (C) Primer extension analysis SL RNA using total RNA clonal
pRTbMTr1 RNAi cell lines 9 days Tet induction. Extension products separated 6  polyacrylamide-8 M urea gel run cognate sequence ladder. (D) Primer extension analysis U1 snRNA pRTbMTr1 RNAi samples. (E) Size analysis SL RNA U1
snRNA medium-resolution acrylamide RNA blotting using oligonucleotide probes TbStloopI TbU1-20, respectively. number days
post-Tet addition indicated. 5S rRNA served loading control.
 6088     ZAMUDIO ET AL.                                                                                                MOL. CELL. BIOL.




   FIG. 4. Absence TbMTr1 affects 5â¬˜ cap 1 3â¬˜ maturation.   Absence TbMTr1 alleles. Shown Southern blot wild-type
(WT) null (KO) clonal cell lines digested XhoI. products resolved 1  agarose gel, visualized ethidium bromide
staining, transferred, probed coding region TbMTr1. Lane M 1-kb ladder (Invitrogen). (B) Altered substrate SL
methylation TbMTr1-null line. Primer extension analysis using total RNA collected wild-type clone 1 TbMTr1-null cell lines, described Fig. 3. (C) Altered cap methylation U1 snRNA measured primer extension. (D) Cap 1-deficient SL RNA correlates accumulation 3â¬˜-extended forms. Total RNAs samples collected wild-type TbMTr1-null cells resolved 6  polyacrylamide-8 M urea gel probed â?¥-32P-labeled oligonucleotide, TbSL-40, SL RNA intron. Mature SL RNA denoted â€œMâ€?.




corresponding cap 3 rarely seen wild-type profiles,          position 1 modification (Fig. 3D). Additional faint bands suggesting addition cap 3 followed rapidly cap 4        unaffected RNAi comigrated positions 3 5. supporting hypothesis TbMTr3 performing               induced samples, increase band migrating A1
2â¬˜-O-ribose methylation adjacent position (64).            apparent, demonstrating RT met lower
profile 3â¬˜ methylations mapped electro-            level impediment methylation position 1. remain-
phoresis extension products 6  polyacryl-            ing cap 1 residual incomplete knockdown amide gel parallel corresponding DNA sequence.            TbMTr1, high relative stability U1 snRNA compared wild-type cells nucleotide A1 SL modified        consumed SL RNA, presence dimethylated 2â¬˜-O ribose dimethylated N6 position         adenine base.  TbMTr1 involved 2â¬˜-O-ribose adenine ring (5), sufficient inhibit extension   methylation U1 snRNA. U1 snRNA likely RT (27, 33). TbMTr1 showed vitro cap 1 ribose             acquires TMG posttranscriptionally, TbMTr1 modification
methylation activity, expected detect difference SL        precede TMG acquisition recognize substrate
intermediate population loss position 1 modi-         caps methylation.
fications occurred RNAi cell lines. Compared nonin-            SL RNA gene transcribed 3â¬˜-extended form duced samples, decrease band comigrating A2         processed exonucleases, including TbSNIP trimming observed, corresponding absence cap 1 modification           end maturation (65). accumulation 3â¬˜-ex-
(Fig. 3C). TbMTr1 RNA knockdown resulted reduction              tended forms detected inhibition exportin 1 SL A2-extension termination vitro activity showed       activity, Sm protein studies, assorted SL mutants (35,
2â¬˜-O-ribose MTase cap 1 activity, concluded TbMTr1            51, 65, 67). Hybridization analysis RNA Tet-induced
methylates ribose position 1 SL cap 1       RNAi cells 2 days postinduction revealed ac- required cell viability. SL intermediate        cumulation substrate SL slower migration (Fig. 3E),
base dimethylation A1 detected unlikely        characteristic 3â¬˜-extended molecules. 3â¬˜-trimming  precede 2â¬˜-O-ribose methylation cap 4 biogenesis.               fects observed U1 snRNA 5S rRNA.
   Kinetoplastid U1 snRNA shares 6 7 nt            Loss modification position 1 SL RNA U1
SL identical methylations position 1 Crithidia fascicu-     snRNA TbMTr1 RNAi lines consistent vitro
lata. 3 nt Crithidia U1 snRNA resistant          enzymatic activity. Position 1 ribose modification does ap-
cleavage RNases alkali, indicating ribose methylation       pear play essential role trans-splicing translation positions (47). determined methylation           detectable effect growth measured induced
status U1 snRNA TbMTr1 RNAi lines primer exten-              cultures.
sion. U1 snRNA extension pattern showed majority                   Additional cap 4 defects absence cap 1 methylation.
species A2 band noninduced cells, corresponding          Given potential importance cap 1 modifications,  VOL. 27, 2007                                                                               RNA CAP 1 RIBOSE METHYLATION                   6089




  FIG. 5. Spliced SL position 4 methylation despite 2â¬˜-O-ribose methylation absence position 1.   Spliced SL methylated position
4 TbMTr1-null lines. poly â«¹-selected mRNA isolated wild-type (WT) TbMTr1-null (KO) cells extended using primer
TbWTexon, complementary exon sequence, described Fig. 3. panel poly â«¹-selected mRNA extended TbSL-40 negative control. (B) Absence 2â¬˜-O-ribose methylation spliced SL. Poly â«¹-selected RNA treated tobacco acid
pyrophosphatase HK phosphatase remove 5â¬˜-m7G cap phosphates, â?¥-32P labeled polynucleotide kinase, digested RNase
T2. ladder alkali-treated RNA (OH) corresponding sequence serves size marker. Black stars indicate common bands labeling procedure; black arrow indicates T2-resistant cap 4 band; white arrow indicates T2-resistant band unique TbMTr1-null
cells.



confirmed absence growth phenotype making                      TbMTr1-null line examined substrate SL RNA
TbMTr1-null mutant line. knock alleles                     length high-resolution RNA blot. wild-type cells SL
TbMTr1, introduced constructions homologous recom-                 RNA present main forms: 141-nt species, bination using flanking UTRs.                                         mature 142-nt molecule (20), 143-nt TbSNIP sub-
   Southern blot wild-type TbMTr1-null T. brucei                 strate, representing 71:29 ratio mature underprocessed
lines probed coding region TbMTr1, confirm-               SL RNA. TbMTr1-null lines showed decrease mature
ing loss alleles (Fig. 4A). Primer extension              142-nt accumulation 144- 150-nt forms, representing
formed total RNA. loss band comigrating                21:79 ratio mature underprocessed SL RNA (Fig. 4D).
A2 TbMTr1-null cells confirmed, rescue           increase 143-nt form indicated nuclear null phenotype reintroduction recombinant                   TbSNIP acted majority SL RNA TbMTr1-
TbMTr1-hemagglutinin gene (data shown). substrate                 null cells.
SL phenotype pronounced null lines                   Lack methylation position 1 SL cap correlates induced RNAi lines, significant increase band           reduced methylation additional cap 4 nucleotides comigrating A1 indicating cap 0 form                removal 3â¬˜-extended poly(U) tail. 3â¬˜-end processing
majority species. decrease levels C3 A5                delay supports role cap 1 methylation biogenesis flected lowered levels intermediate methylations po-            SL RNA. Methylations downstream ribose-deficient cap
sitions 2 4. cap 0 extension product 48.1                   1 nucleotide indicate TbMTr2 TbMTr3 activities presence TbMTr1-null cells, compared 19  wild                independent modification(s) position.
type, implying kinetics cap 4 formation               Absence 2â´•-O-methylation position 1 TbMTr1-null altered absence cap 1.                                      mRNA. TbMTr2 TbMTr3 studies demonstrate 
   U1 snRNA complete loss band corresponding                 methylated SL trans spliced. examined cap structure cap 1 TbMTr1-null cells (Fig. 4C). U2 U4                    mRNA TbMTr1-null cells assess methylation
snRNAs, carry cap 1 methylations (47), showed               pattern trans-spliced translation-competent tran-
differences TbMTr1-null line primer extension (data             scripts. shown). cap analysis complicated                   oligonucleotide complementary SL exon, TbWTexon,
stream methylation U1 snRNA, loss band position              used primer extension reactions poly â«¹ RNA (Fig.
1 revealed base ribose methylations absent;            5A). extension wild-type mRNA reflects SL stated definitively substrate SL.                      majority position 4 modifications, contrast cap 4
 6090     ZAMUDIO ET AL.                                                                                                       MOL. CELL. BIOL.




   FIG. 6. TbMTr1-GFP localizes nucleoplasm. Clonal YTAT cell lines used generate line containing GFP gene fused frame TbMTr1 gene endogenous locus. expressed TbMTr1-GFP fusion protein visualized light microscopy UV light
illumination. positions nuclear kinetoplast DNAs revealed staining DAPI. cells shown phase contrast.



intermediates captured substrate extensions. difference             virtual absence 3â¬˜ mature substrate SL TbMTr1-null observed wild-type TbMTr1-null lines,                 population shown high-resolution RNA analysis, identical profiles showing position 4-modified SL             majority SL signal nucleoplasm likely 
majority species (â¬Ž 95 ). control free SL RNA                    tributed underprocessed forms, indicating delay nuclear
contamination, poly â«¹ RNA assayed TbSL40                   egress.
intron probe, yielding product. mRNA samples subjected RNase T2 digestion confirm cap 1 undermethyl-                                        DISCUSSION
ation. RNase T2 nonspecific endonuclease cleave RNA 2â¬˜-O-ribose methylated. RNase T2                       report identification characterization sistant fragment migrated slightly faster corre-            eukaryotic cap 1 2â¬˜-O-ribose MTase acts SL RNA, sponding 5-nt OH-degradation marker obtained                     mRNA, U1 snRNA T. brucei.
wild-type mRNA (Fig. 5B, black arrow) representing fully              AdoMet-dependent methylation m7G-capped substrate
modified cap 4 (55). cap 4, T2-resistant band                 shown recombinant TbMTr1 vitro. Knockout observed mRNA derived TbMTr1-null cells,               TbMTr1 alleles resulted viable cells defects T2-resistant band migrating 1-nt 2-nt mark-             ribose modification cap 1 position SL RNA U1
ers revealed (Fig. 5B, white arrow). novel band               snRNA. TbMTr1-null cells displayed delay processing represent nucleotide A1 N6 monomethylation dimethyl-              SL RNA loss 2â¬˜-O-ribose methylation position 1
ation;  assignment confirmed addi-                corresponded decrease subsequent cap methylation tional analysis.                                                          accumulation 3â¬˜-extended forms.
   mRNA TbMTr1-null cells lacks complete cap 4,                     significance mRNA cap 1 evident main-
consistent absence ribose methylation position 1.          tenance multiple viral systems, cap ribose methyl-
Subsequent activities cap 4 maturation pathway occur               ation increases binding ribosomes (37) impacts transla-
efficiently absence TbMTr1 activity;  kinetic           tional control viral transcripts (8). influenza virus,
delays apparent substrate profile.                             priming mRNA transcription efficient stolen
   TbMTr1 localizes nucleus T. brucei. Cap 1 meth-              host caps possess cap 1 (7). function snRNA cap 1
ylation Sm complex independent SL RNA (35, 51, 65).                known. role TbMTr1 processing SL RNA investigate spatial temporal aspects cap 1 synthesis,           does exclude synergistic role cap 1 ribose methylation determined subcellular localization TbMTr1               translation. viral cap 2â¬˜-O-ribose MTases cyto- substrate SL TbMTr1-null line.                                   solic eIF4E translation initiation factor, recognition    TbMTr1-GFP fusion created introduced                m7G cap occurs coplanar aromatic residues (44).
cognate genomic locus. Localization fusion protein coin-           eIF4E proteins trans-splicing organisms Caenorhab-
cided nuclear DAPI stain (Fig. 6), indicating           ditis elegans Leishmania major distinguish majority protein nucleoplasmic. GFP fusions           different cap structures including base ribose modifications lead mislocalization, especially overexpressed, nu-           (22, 63), reflecting downstream discrimination effects
clear concentration typical default. RNA-fluorescent        cap 1 enzymes TbMTr1.
situ hybridization TbMTr1-null cells SL RNA revealed               TbMTr1 retained positional specificity related
cytosolic overaccumulation (data shown), seen          baculovirus MTase 1 capping enzyme, contrast Sm protein knockdown experiments.                                         changes positional specificity cap 2 cap 3 TbMTr2
   SL TbMTr1 localizations support delay                 TbMTr3, kinetoplastid homologs vaccinia virus
processing kinetics cap 1-deficient SL substrates. Nuclear            cap 1 MTase VP39 (21, 49). Horizontal gene transfer SL retention induced poisoning export                  viruses eukaryotic cells given rise pathway using leptomycin B, resulting undermethylated              genes, followed altered enzyme specificity viral cap
3â¬˜-extended molecules (67). phenotypic shift                   1 modification protists. TbMTr1 eukaryotic
TbMTr1-null line indicates majority SL population             orthologs likely derived similar viral origins undergoing biogenesis, wild-type cells approxi-            additional domains absent viral orthologs mately 79  SL completed journey. Considering               important activity specificity. eukary-
 VOL. 27, 2007                                                                             RNA CAP 1 RIBOSE METHYLATION                             6091


otic members TbMTr1 family contain N-terminal exten-           LC07032. J.R  supported NSF Louis Stokes Alliance sions 40 200 aa predicted disordered.        Minority Participation Award HRD-0115115:3 USPHS National
                                                                      Research Service Award GM07104.
homologs metazoa contain additional C-terminal 
mains related guanylyltransferases lack catalytic resi-                                         REFERENCES
dues (15).                                                             1. Alexandrov, ,  Chernyakov, W. Gu, S. L. Hiley, T. R. Hughes, E. J.
   Cap 4 formation T. brucei linear, methylations              Grayhack, E. M. Phizicky. 2006. Rapid tRNA decay result lack
starting 5â¬˜ end (34). Based nuclear localization          nonessential modifications. Mol. Cell 21:87â€“96.
                                                                       2. Arhin, G. K., H. Li, E. Ullu, C. Tschudi. 2006. protein related TbMTr1-GFP SL cap 1 phenotype Sm complex-                   vaccinia virus cap-specific methyltransferase VP39 involved cap 4 mod-
deficient transcripts (35, 51, 65), TbMTr1 acts independently             ification Trypanosoma brucei. RNA 12:53â€“62. Sm protein binding facilitates biogenesis SL             3. Arhin, G. K., E. Ullu, C. Tschudi. 2006. 2â¬˜-O-Methylation position 2
                                                                          trypanosome spliced leader cap 4 mediated 48kDa protein
RNA. TbMTr2 vitro activity does require prior cap 1                related vaccinia virus VP39. Mol. Biochem. Parasitol. 147:137â€“139.
modification (19), consistent vivo results            4. Banerjee,  K. 1980. 5â¬˜-terminal cap structure eucaryotic messenger
                                                                          ribonucleic acids. Microbiol. Rev. 44:175â€“205.
TbMTr2 TbMTr3. Subsequent 5â¬˜-end processing                 5. Bangs, J. D., P. F. Crain, T. Hashizume, J.  McCloskey, J. C.
enhanced cap 1, reflecting decrease ability                Boothroyd. 1992. Mass spectrometry mRNA cap 4 trypanosomatids
TbMTr2 TbMTr3 recognize A1 ribose-methylation-                 reveals novel nucleosides. J. Biol. Chem. 267:9805â€“9815.
                                                                       6. Bisaillon, M., G. Lemay. 1997. Viral cellular enzymes involved deficient substrate inaccessibility substrate            synthesis mRNA cap structure. Virology 236:1â€“7. nucleus-localized enzymes, potentially inefficient        7. Bouloy, M., S. J. Plotch, R. M. Krug. 1980. 7-methyl trafficking substrate SL RNA. cap 1 base MTase(s)              2â¬˜-O-methyl groups cap mRNA strongly influence ability act
                                                                          primer influenza virus RNA transcription. Proc. Natl. Acad. Sci. USA identified, apparent absence dimethy-            77:3952â€“3956.
lation U1 snRNA TbMTr1-null cells suggests require-            8. Brownlee, G. G., E. Fodor, D. C. Pritlove, K. G. Gould, J. J. Dalluge.
ment TbMTr1 activity additional modifications;                1995. Solid phase synthesis 5â¬˜-diphosphorylated oligoribonucleotides                                                                           conversion capped m7Gppp-oligoribonucleotides use primers
appearance novel band mRNA RNase T2 digestions                  influenza virus RNA polymerase vitro. Nucleic Acids Res. 23:2641â€“
indicates SL base modification proceed po-               2647.
                                                                       9. Bujnicki, J. M., L. Rychlewski. 2001. Reassignment specificities sition 1 ribose methylation, primer extension detection            cap methyltransferase domains reovirus â?­2 protein. Genome Biol. base intermediate blocked downstream methylations.              2:0038.1â€“0038.6.
Developed assays using dimensional TLC cap analysis           10. Camper, S. , R. J. Albers, J. K. Coward, F. M. Rottman. 1984. Effect
                                                                          undermethylation mRNA cytoplasmic appearance half-life. Mol. dependent isolation RNase T2-resistant fragment              Cell. Biol. 4:538â€“543. lost TbMTr1-null cells. Complete cap 4        11. Coleman, T. M., G. Wang, F. Huang. 2004. Superior 5â¬˜ homogeneity thought required trans-splicing SL                  RNA ATP-initiated transcription T7 phi 2.5 promoter. Nu-
                                                                          cleic Acids Res. 32:e14.
mRNAs (32, 53, 56, 57). knockout TbMTr1                12. Decatur, W. , M. J. Fournier. 2003. RNA-guided nucleotide modifi-
underscores independence complete cap 4 formation                  cation ribosomal RNAs. J. Biol. Chem. 278:695â€“698.
                                                                      13. Decatur, W. , M. J. Fournier. 2002. rRNA modifications ribosome trans-splicing, shown exon mutagenesis studies (52,             function. Trends Biochem. Sci. 27:344â€“351.
68).                                                                  14. Djikeng, , L. Ferreira, M. Dâ€™Angelo, P. Dolezal, T. Lamb, S. Murta, V.
   TbMTr1 nonviral enzyme family               Triggs, S. Ulbert,  Villarino, S. Renzi, E. Ullu, C. Tschudi. 2001.
                                                                          Characterization candidate Trypanosoma brucei U1 small nuclear RNA
defined cap 1 MTase. humans cap 1 mRNA 2â¬˜-O-                  gene. Mol. Biochem. Parasitol. 113:109â€“115.
ribose MTase activity partially purified resides      15. Feder, M., J. Pas, L. S. Wyrwicz, J. M. Bujnicki. 2003. Molecular nucleus; subsequent cap 2 2â¬˜-O-ribose methylation occurs              phylogenetics RrmJ/fibrillarin superfamily ribose 2â¬˜-O-methyltrans-
                                                                          ferases. Gene 302:129â€“138. cytoplasm (30, 42). appearance cap ribose meth-         16. Freistadt, M. S., G.  M. Cross, H. D. Robertson. 1988. Discontinuously
ylation Xenopus laevis maternal transcripts correlates            synthesized mRNA Trypanosoma brucei contains highly methylated
                                                                          5â¬˜ cap structure, m7GpppA C(2â¬˜-O)mU  J. Biol. Chem. 263:15071â€“
translation initiation (25). Inhibition ribose internal            15075.
adenosine N6-methylation mammalian cells leads               17. Furuichi, Y.,  J. Shatkin. 2000. Viral cellular mRNA capping: past
creased cytoplasmic half-life, suggestive role trafficking        prospects. Adv. Virus Res. 55:135â€“184.
                                                                      18. Gillian-Daniel, D. L., N. K. Gray, J. Astrom,  Barkoff, M. Wickens. processing mRNA transcripts (10). Interestingly,                  1998. Modifications 5â¬˜ cap mRNAs Xenopus oocyte matu-
TbMTr1 family member Caenorhabditis elegans caused ma-                 ration: independence changes poly  length impact trans-
ternal sterility targeted RNAi (46).                              lation. Mol. Cell. Biol. 18:6152â€“6163.
                                                                      19. Hall, M. P., C. K. Ho. 2006. Functional characterization 48 kDa
   point, role cap 4 kinetoplastid biology              Trypanosoma brucei cap 2 RNA methyltransferase. Nucleic Acids Res. 34:
remains open question. case tRNA rRNA,                5594â€“5602.
                                                                      20. Hitchcock, R. , G. M. Zeiner, N. R. Sturm, D.  Campbell. 2004. effects cap methylations cumulative syner-              3â¬˜-termini small RNAs Trypanosoma brucei. FEMS Microbiol. Lett.
gistic. Family-wide pathway conservation suggests key, func-            236:73â€“78.
tionally selected role. Likewise prevalence diversity      21. Hodel,  E., P. D. Gershon, X. Shi, S. M. Wang, F.  Quiocho. 1997.
                                                                          Specific protein recognition mRNA cap alkylated base. Nat.
higher-order cap structures eukaryotes viruses allude           Struct. Biol. 4:350â€“354. primary function appreciate fully.              22. Jankowska-Anyszka, M., B. J. Lamphear, E. J. Aamodt, T. Harrington, E.
                                                                          Darzynkiewicz, R. Stolarski, R. E. Rhoads. 1998. Multiple isoforms                      ACKNOWLEDGMENTS                                      eukaryotic protein synthesis initiation factor 4E Caenorhabditis elegans                                                                           distinguish mono- trimethylated cap structures. J. Biol. Chem.
   thank Jay Bangs pKO vectors; Thomas Seebeck             273:10538â€“10542.
pMOT vectors; Kent Hill YTAT cells use Zeiss       23. Johnson, P. J., J. M. Kooter, P. Borst. 1987. Inactivation transcription
                                                                          UV irradiation T. brucei provides evidence multicistronic tran-
fluorescence microscope; Murray Schnare advice cap analysis;       scription unit including VSG gene. Cell 51:273â€“281. Miriam Giardini, Robert Hitchcock, Sean Thomas, Scott         24. Jones, D. T., W. R. Taylor, J. M. Thornton. 1992. rapid generation
Westenberger stimulating discussions.                                 mutation data matrices protein sequences. Comput. Appl. Biosci.
   work supported NIH grant AI034056           8:275â€“282.
grants Ministry Education Czech Republic 2B06129     25. Kuge, H., J. D. Richter. 1995. Cytoplasmic 3â¬˜ poly  addition induces
 6092         ZAMUDIO ET AL.                                                                                                                         MOL. CELL. BIOL.

      5â¬˜ cap ribose methylation: implications translational control maternal     47. Schnare, M. N., M. W. Gray. 1999. candidate U1 small nuclear RNA
      mRNA. EMBO J. 14:6301â€“6310.                                                           trypanosomatid protozoa. J. Biol. Chem. 274:23691â€“23694.
26.   Kumar, S., K. Tamura, M. Nei. 2004. MEGA3: integrated software            48. Shatkin,  J., J. L. Manley. 2000. ends affair: capping       molecular evolutionary genetics analysis sequence alignment. Brief.               polyadenylation. Nat. Struct. Biol. 7:838â€“842.
      Bioinform. 5:150â€“163.                                                             49. Shi, X., P. Yao, T. Jose, P. Gershon. 1996. Methyltransferase-specific
27.   Lafontaine, D. L. J., T. Preiss, D. Tollervey. 1998. Yeast 18S rRNA               domains VP-39, bifunctional protein participates modi-
      dimethylase Dim1p: quality control mechanism ribosome synthesis?                 fication mRNA ends. RNA 2:88â€“101.
      Mol. Cell. Biol. 18:2360â€“2370.                                                    50. Shuman, S. 2002. messenger RNA capping tells eukaryotic
28.   Lamb, J. R., V. Fu, E. Wirtz, J. D. Bangs. 2001. Functional analysis       evolution. Nat. Rev. Mol. Cell Biol. 3:619â€“625.
      trypanosomal AAA protein TbVCP trans-dominant ATP hydrolysis                 51. Sturm, N. R., D.  Campbell. 1999. role intron structures       mutants. J. Biol. Chem. 276:21512â€“21520.                                              trans-splicing cap 4 formation Leishmania spliced leader RNA.
29.   Lane, B. 1998. Historical perspectives RNA nucleoside modifications, p.            J. Biol. Chem. 274:19361â€“19367.
      1â€“20. H. Grosjean R. Benne (ed.), Modification editing RNA.
                                                                                        52. Sturm, N. R., J. Fleischmann, D.  Campbell. 1998. Efficient trans-
      ASM Press, Washington, DC.
                                                                                            splicing mutated spliced leader exons Leishmania tarentolae. J. Biol.
30.   Langberg, S. R., B. Moss. 1981. Post-transcriptional modifications                                                                                             Chem. 273:18689â€“18692.
      mRNA. Purification characterization cap cap II RNA (nucle-
                                                                                        53. Tschudi, C., E. Ullu. 2002. Unconventional rules small nuclear RNA
      oside-2â¬˜-)-methyltransferases HeLa cells. J. Biol. Chem. 256:10054â€“
                                                                                            transcription cap modification trypanosomatids. Gene Expr. 10:3â€“16.
      10060.
31.   Lapeyre, B., S. K. Purushothaman. 2004. Spb1p-directed formation           54. Tycowski, K. T.,  H.  P. J. Graham, J.  Steitz. 1998. Modification
      Gm2922 ribo